1. Introduction {#s0005}
===============

Saturated fatty acids (SFAs) represent endogenously synthesized and dietary compounds that substantially contribute to tissue building and serve as an energy source as well as facilitating the development of diseases [@b0005; @b0010; @b0015]. In mammalian cells, SFAs vary in their carbon chain lengths from 2 to 24 carbons, and the different chain lengths impart various physiological activities to the fatty acids in many cell types [@b0005; @b0010; @b0015]. Current evidence suggests that an accumulation of long-chain (LC)-SFAs (more than 14 carbons) leads to lipid-mediated cell dysfunction [@b0005; @b0010; @b0015]. Many investigators have also demonstrated that LC-SFAs, especially palmitate and stearate, induce apoptosis within a variety of cell types [@b0020; @b0025; @b0030; @b0035; @b0040; @b0045; @b0050; @b0055; @b0060; @b0065; @b0070]. LC-SFAs must be activated to long-chain acyl-CoA for oxidation or use in cellular processes such as membrane formation and lipid storage. Many studies have reported that LC-SFAs induce cell death by triggering production of reactive oxygen species (ROS) [@b0075], causing dysfunction of membrane fluidity by changing the fatty acid content [@b0020; @b0080], and inducing stress signals [@b0025; @b0030; @b0035; @b0040; @b0100].

On the other hand, long chain monounsaturated fatty acids (MUFAs), such as oleate and palmitoleate, have lower cytotoxicity than LC-SFAs, but a combination results in an even lower cytotoxic effect, suggesting that MUFAs can inhibit LC-SFA cytotoxicity [@b0020; @b0045; @b0085; @b0090; @b0095; @b0100; @b0185]. Following treatment of cells with palmitate and oleate, the intracellular membrane composition of oleate increases to maintain high fluidity and suppress stress signals induced by the treatment with palmitate alone [@b0105; @b0110]. Thus, it appears that MUFAs can promote detoxification of LC-SFAs by altering their partitioning within cells.

In contrast to LC-SFAs, medium chain-saturated fatty acids (MC-SFAs) such as caprylate (8 carbons), caproate (10 carbons), and laurate (12 carbons), are thought to be less cytotoxic than LC-SFAs [@b0115]. MC-SFAs have physical and metabolic properties that are distinct from those of LC-SFAs, which make them a readily available cellular energy source. Few papers have studied cell death induction by MC-SFAs [@b0120], and any interaction between MC-SFA and oleate in the context of cell death has not yet been evaluated precisely. In this report, we found that co-stimulation of laurate with oleate promoted more cytotoxic activity than each alone in several cell types. We also showed that the combination of fatty acids enhanced the formation of lipid droplets and increased fatty acid uptake, especially laurate, which greatly enhanced oleate uptake. Our results highlight the ability of laurate to increase fatty acid uptake and decrease the threshold of oleate cytotoxicity.

2. Materials and methods {#s0010}
========================

2.1. Cell culture {#s0015}
-----------------

Cells were obtained from the RIKEN Cell Bank (Tsukuba, Japan) and the Health Science Research Resources Bank (HSRRB) (Osaka, Japan) and maintained at 37 °C in a humidified 5% (v/v) CO~2~ atmosphere in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS), 10 U/ml penicillin, and 10 g/ml streptomycin, as described previously [@b0125; @b0130].

2.2. Fatty acid treatment {#s0020}
-------------------------

Fatty acids were obtained from Wako (Osaka, Japan), Sigma (St. Louis, MO), and Tokyo Chemical Industry Co., Ltd. (TCI, Tokyo, Japan). Stock fatty acid solutions (100 mM) in dimethyl sulfoxide (DMSO) were diluted in medium containing 0.5% (w/v) fatty acid-free bovine serum albumin. Cells were seeded at 2 × 10^5^/well into 96-well plates. After 24 h of culture, fatty acids (0.5--1 mM) were added to the media. All experiments were carried out at 37 °C under a humidified 5% (v/v) CO~2~ atmosphere.

2.3. MTT assay {#s0025}
--------------

The MTT assay was used to determine cell viability; the assay is based on bioreduction of the tetrazolium compound MTT \[3-(4,5-dimethylthiazolyl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt\] and the electronic coupling reagent phenazine ethosulfate (PES) to yield a colored formazan product, the absorbance of which is proportional to the number of viable cells. Briefly, after fatty acid treatment for 24--48 h, MTT solution was added to media, the plates were incubated at 37 °C for 2--4 h, and the absorbance of each supernatant was measured at 535 nm, according to the manufacturer's instructions.

2.4. Flow cytometry {#s0030}
-------------------

Cells were treated with fatty acids for 1--6 h and stained with NucView™ 488 (Biotium, Hayward, CA) to determine the extent of caspase-3 activation; with tetramethylrhodamine methylester (TMRM, Invitrogen) to assess the integrity of the mitochondrial membrane; or with 2′,7′dichlorofluorescin diacetate (DCFDA, Invitrogen) to detect reactive oxygen species (ROS), according to the respective manufacturers' instructions. Fluorescent cells were detected using a JSAN platform (Bay Bioscience, Kobe, Japan) and cell populations were analyzed with the aid of Flowjo software (TreeStar, Ashland, OR).

2.5. Measurement of fatty acid uptake {#s0035}
-------------------------------------

Cells were incubated with a fluorescent fatty acid analog, C1-BODIPY 500/510 dodecanoic acid (Molecular Probes, Eugene, OR), or radioisotope-labeled fatty acids, thus \[1-^14^C\]-oleate, laurate, or palmitate (PerkinElmer, Waltham, MA), with or without addition of other fatty acids, for 1--4 h [@b0135]. Then the cells were washed three times with PBS, lysed in NaOH, and the suspensions were neutralized with acetic acid. Then the cell lysates were transferred to either 96-well black microwell-plates or scintillation vials containing Sintisol (Nacarai Tesque, Kyoto, Japan). Fluorescence intensities and radioactivity levels were measured using a Fluoroscan Ascent platform (Thermo-Scientific, Rochester, MA) or a liquid scintillation counter, respectively.

3. Results and discussion {#s0040}
=========================

Previous reports have shown that palmitate, an LC-SFA, induced cell death in several cell types but that its cytotoxicity was ameliorated when combined with oleate [@b0010; @b0015]. Although the MC-SFAs (caprylate, caproate, and laurate) were less cytotoxic than palmitate, any combinatory effect with oleate on cytotoxicity remains unknown. To test the combinatory effect of oleate with MC-SFAs on cell viability, we stimulated HT1080 cells, a human fibrosarcoma cell line, using MC-SFAs with or without oleate. When the cells were stimulated with each fatty acid alone, palmitate was more cytotoxic than laurate and oleate, but these fatty acids still exhibited cytotoxic effects at higher concentrations ([Fig. 1](#f0005){ref-type="fig"}). As shown in previous studies, co-stimulation by palmitate (0.5 mM) with oleate (1 mM) caused much less lipotoxicity (more than 80% viability) than that by palmitate alone; however, a mixture of MC-SFA and oleate effectively induced cell death, especially in the case of laurate (less than 10% viability; [Fig. 2](#f0010){ref-type="fig"}a and b).

To investigate whether the combination of laurate and oleate exerts the same effects in other cell lines, we tested the combination on 10 additional human and mouse cancer cell lines (A549, Caco2, Ehrlich, HeLa, HepG2, Jurkat, Neuro2a) and cell lines derived from normal tissues (JB6, MRC-5, NIH-3T3). The combination induced a variable but appreciable degree of cell death in all cell lines tested ([Fig. 3](#f0015){ref-type="fig"}). These results suggest that the effect of palmitate is different from that of laurate when mixed with oleate.

Long-chain saturated fatty acids have been shown in several cell types to produce reactive oxygen species (ROS), decrease mitochondrial membrane potential, and induce caspase-3 activation, which are hallmark features of LC-SFA-induced cell death [@b0010; @b0015; @b0075]. To assess the effects of a combination of laurate and oleate on ROS production, HT1080, HepG2, and Jurkat cells were treated with laurate in combination with oleate for 1 h. As shown in [Fig. 4](#f0020){ref-type="fig"}, ROS levels were increased to a greater extent by exposure of Jurkat cells to the combination (6-fold); however, the effects were less in HT1080 and HepG2 cells (less than 3-fold) than Jurkat cells. The caspase-3 activation induced by laurate with oleate occurred at 6 h in Jurkat cells (more than 60%), but not in HT1080 or HepG2 cells (less than 20%, [Fig. 5](#f0025){ref-type="fig"}). The loss of mitochondrial membrane potential is one of the steps preceding caspase activation during apoptosis. As shown in [Fig. 6](#f0030){ref-type="fig"}, the combination of laurate and oleate induced a significant increase in the percentage of Jurkat cells with low mitochondrial membrane potential (more than 60%) at 6 h; however, the treatment did not induce depolarization of the membrane potential in HT1080 and HepG2 cells (less than 10%), suggesting that apoptotic processes such as ROS production, caspase-3 activation, and decreased mitochondrial membrane potential induced by the combination of laurate and oleate occur in a cell-type-dependent manner.

It has been shown that triacylglycerol (TG) synthesis and the formation of lipid droplets are stimulated by oleate as well as laurate in tissue culture cells [@b0140; @b0145; @b0150; @b0155]. Therefore, we investigated the effect of the combination of fatty acids on lipid droplet formation using a fluorescent indicator. Lipid droplet formation was increased by treatment with either laurate or oleate alone; however co-treatment with laurate and oleate dramatically enhanced lipid formation in all cell types ([Fig. 7](#f0035){ref-type="fig"}).

Next, we examined the effect of fatty acid uptake by each fatty acid alone or by a mixture of laurate and oleate. Although the uptake of fluorescent BODIPY-labeled fatty acid was enhanced by treatment with oleate alone, but not laurate or palmitate, the fluorescence intensity by oleate was considerably greater upon co-stimulation with laurate ([Fig. 8](#f0040){ref-type="fig"}). We also investigated how the uptake of each fatty acid was affected by other fatty acids. Co-incubation of ^14^C-labeled oleate with palmitate did not affect the influx of ^14^C-labeled oleate; however, laurate dramatically enhanced its incorporation ([Fig. 9](#f0045){ref-type="fig"}a). On the other hand, the effect of oleate on the influx of ^14^C-labeled laurate influx was cell type-dependent ([Fig. 9](#f0045){ref-type="fig"}b). We also confirmed that laurate did not enhance the influx of ^3^H-labeled 2-deoxyglucose ([Fig. 10](#f0050){ref-type="fig"}).

We have herein shown that lipotoxicity exerted by a combination of laurate and oleate was dramatically greater than the lipotoxicity of either fatty acid alone; in contrast to what was noted using a mixture of palmitate and oleate. Because non-metabolized palmitate is unable to induce cell death, LC-SFA must be converted into acyl-CoA and then incorporated into membrane lipids or lipid storage [@b0020; @b0050; @b0100]. The partitioned LC-SFA is believed to induce ROS, and endoplasmic reticulum stress, caused by membrane dysfunction attributable to decreased membrane fluidity [@b0020; @b0080]. Oleate has been thought to suppress the lipotoxicity of LC-SFA by competing with the undesired localization of LC-SFA to maintain the membrane fluidity, suggesting that the balance between saturated and unsaturated fatty acids in the membrane is critical in terms of cell death (from stress) or survival (when stress is absent) [@b0105; @b0110].

Although oleate can detoxify LC-SFA, that fatty acid was toxic to several cell lines, but less so to LC-SFA. In addition, the mechanisms of oleate-induced cell death differ among cell types [@b0115; @b0170; @b0175; @b0180]. We also found that oleate had cytotoxic effects at higher concentrations than laurate, and the lipotoxicity of oleate was greater than that of laurate ([Fig. 1](#f0005){ref-type="fig"}). Formation of lipid droplets, in addition to lipotoxicity, was enhanced by a combination of laurate and oleate. Laurate has been shown to enhance rectal absorption of propranolol [@b0160], to improve intestinal absorption of thyrotropin [@b0165], and to stimulate triacylglycerol synthesis [@b0140; @b0145]. We have clearly shown that laurate also enhances fatty acid uptake. Although laurate also acts as a detergent, we found that laurate increased the uptake of fatty acids, but not glucose, suggesting that laurate somehow affects the machinery of fatty acid uptake. Several studies have shown that fatty acid-induced cell death is not attributable to overloading of cells with lipid droplets [@b0060; @b0095; @b0150; @b0155; @b0185], suggesting that lipid droplet formation by the laurate/oleate combination probably does not induce cell death. From these results, we hypothesize that when laurate enhances the cellular uptake of oleate, the excess free oleate which has not been stored as lipid droplets induces stress, causing the cells to eventually die. Stress symptoms, including ROS production, mitochondrial dysfunction, and caspase activation differed among various cell types treated with laurate and oleate, suggesting that the stress signals and cell death pathways are activated by excess oleate, and depend upon the cell type. Although susceptibility to stress caused by excess oleate requires lipid droplet formation, the precise role played by such droplets in cell death requires further investigation.

In this report, the combination of laurate and oleate increased not only the cytotoxic effects, but also lipid droplet formation and fatty acid uptake, compared to treatment with each fatty acid alone. However the co-stimulation-induced stress signals and cell death pathways differed among cell types. The findings of the present study suggest that laurate increases fatty acid uptake, allowing the cells to obtain excess amounts of oleate to lower the threshold for the cytotoxic effects of oleate. Given these findings, laurate may be useful for promoting intestinal absorption of fatty acids in cases of malnutrition. Future studies are needed to elucidate the exact mechanism by which laurate affects fatty acid uptake.
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![Lipotoxicity induced by palmitate, laurate, or oleate alone. HT1080 cells were treated with palmitate, laurate, or oleate for 24 h. Cell viability was assessed using the MTT assay, as described in Section [2](#s0010){ref-type="sec"}. The data are the means ± SDs (n = 3).](gr1){#f0005}

![Effect of oleate on lipotoxicity induced by caprylate, caprate, laurate, or palmitate. (a) HT1080 cells were treated with caprylate, caprate, laurate, or palmitate in the presence or absence of oleate for 24 h. Cell viability was assessed using the MTT assay, as described in Section [2](#s0010){ref-type="sec"}. The data are the means ± SDs (n = 3). (b) Representative phase-contrast micrographs taken at the conclusion of the experiments.](gr2){#f0010}

![Viabilities of human and mouse cell lines upon co-exposure to laurate or palmitate, and oleate. The viabilities of human (A549, Caco2, Ehrlich, HeLa, HepG2, and Jurkat) and mouse (Neuro2a) cancer cell lines, and normal human (MRC-5) and mouse (JB6, NIH3T3) cell lines, were assessed as described in the legend to [Fig. 1](#f0005){ref-type="fig"}. The data are the means ± SDs (n = 3).](gr3){#f0015}

![ROS production upon co-exposure to laurate and oleate. Cells were treated with fatty acids for 1 h and next treated with DCFDA. The histograms show the mean fluorescence intensities of untreated cells (shaded boxes) and co-stimulated cells (white boxes). Each data point is the average MFI (in arbitrary units, AUs) of ROS-producing cells compared to untreated cells (AU = 1). The data are representative of at least three separate experiments.](gr4){#f0020}

![Caspase-3 activation upon co-addition of laurate and oleate. Cells were stimulated by fatty acids for 6 h and next treated with NucView™ 488. The histograms show the mean fluorescence intensities of untreated cells (shaded boxes) and co-stimulated cells (white boxes). Each data point is the population (%) of cells with the increased mean fluorescence intensity (MFI) characteristic of caspase-3 activated cells. The data are representative of at least three separate experiments.](gr5){#f0025}

![Mitochondrial membrane dysfunction upon co-addition of laurate and oleate. Cells were stimulated by fatty acids for 6 h and then treated with TMRM. The histograms show the mean fluorescence intensities of untreated cells (shaded boxes) and co-stimulated cells (white boxes). Each data point is the population (%) of cells with the decreased mean fluorescence intensity (MFI) characteristic of mitochondria that have lost their membrane potential (Mit). The data are representative of at least three separate experiments.](gr6){#f0030}

![Lipid accumulation following co-addition of laurate and oleate. Cells were stimulated with fatty acids for 6 h and then stained with Nile Red to detect lipid droplets. The histograms show the mean fluorescence intensities (MFIs) of untreated cells (shaded boxes) and stimulated cells (white boxes) with laurate (upper), oleate (middle), or the combination (lower). Each number is the average MFI (in arbitrary units, AUs) compared to that of untreated cells (AU = 1), reflecting lipid droplet accumulation (lipid). The data are representative of at least three separate experiments.](gr7){#f0035}

![Fatty acid uptake upon co-addition of laurate and oleate*.* Cells were treated with the indicated fatty acids and BODIPY for 4 h. BODIPY fluorescence was detected using a Fluoroscan. BODIPY uptakes are presented as MFIs (in arbitrary units, AUs) compared to that of untreated cells (AU = 1). The data are the means ± SDs (n = 3).](gr8){#f0040}

![Oleate influx is enhanced by laurate*.* Cells were treated with the indicated fatty acids and ^14^C-labeled oleate (a) or laurate (b) for 1--3 h. Radioactivity levels (cpm) were measured using a scintillation counter as described in Section [2](#s0010){ref-type="sec"}.](gr9){#f0045}

![2-Deoxyglucose uptake by laurate. Cells were treated with the indicated fatty acids and ^3^H-labeled 2-deoxyglucose for 1--3 h. Radioactivity levels (cpm) were measured using a scintillation counter as described in Section [2](#s0010){ref-type="sec"}.](gr10){#f0050}
